RECRUITING

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Talk to us

Conditions

Open-Angle GlaucomaHydrus MicrostentOMNI Surgical SystemPhacoemulsification

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Official Title

Real-World Efficacy of Hydrus Microstent With OMNI Surgical System in Combination With Phacoemulsification: a Retrospective Analysis

Quick Facts

Study Start:2025-03-31
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06953349

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
  2. * have Glaucoma
  1. * Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
  2. * Patients with refractory CME or CME persisting 3 months or more post-operatively
  3. * Patients with incomplete IOP, medication logs or VF data within post-operative period
  4. * Prior incisional surgery or MIGS

Contacts and Locations

Study Contact

Derek J Arnson, Master of Education
CONTACT
4804201005
derek.arnson@researchavp.com
Christine Funke, Medical Doctor
CONTACT
4804201005
christine.funke@BDPEC.com

Principal Investigator

Christine Funke, Medical Doctor
PRINCIPAL_INVESTIGATOR
Barnet Dulaney Perkins Eye Centers

Study Locations (Sites)

Barnet Dulaney Perkins Eye Center
Mesa, Arizona, 85206
United States

Collaborators and Investigators

Sponsor: Barnet Dulaney Perkins Eye Centers

  • Christine Funke, Medical Doctor, PRINCIPAL_INVESTIGATOR, Barnet Dulaney Perkins Eye Centers

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-31
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-03-31
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Hydrus Microstent
  • OMNI Surgical System
  • Phacoemulsification

Additional Relevant MeSH Terms

  • Open-Angle Glaucoma